Bausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024. In the quarter to June 2026, revenue grew 9.08%, EPS grew 77.8%, free cash flow grew 251.9% and total debt rose 3.15%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow BLCO
Bausch + Lomb Corporation (BLCO) P/E ratio
Bausch + Lomb Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 946× (February 2023) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 786× | 1,966.00% |
| FY2021 | 38.0× | 0.00% |
| FY2020 | 38.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 18 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| BLCO Bausch + Lomb Corporation | n/m |
| TFX Teleflex Incorporated compare | n/m |
| ATR AptarGroup, Inc. compare | 22.2× |
| ALGN Align Technology, Inc. compare | 25.6× |
| STVN Stevanato Group S.p.A. compare | 33.8× |
| MMSI Merit Medical Systems, Inc. compare | 36.4× |
| NVST Envista Holdings Corporation compare | 38.8× |
| ICUI ICU Medical, Inc. compare | 136× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)